Contact Us.Site Map.
Offering hope, help, and support to mesothelioma patients and their families.Get Help Now.

Archive for May, 2004

Thursday, May 27th, 2004 - More than 1550 companies and individuals throughout New York State have been mailed notifications of their status as victims of illegal asbestos abatement and testing by Albany company

Thursday, May 6th, 2004 - Celebrex Hits Mesothelioma, in Lab Studies: COX-2 inhibitor Celebrex, usually prescribed for arthritis, has a marked effect on the asbestos-related cancer malignant mesothelioma in lab and animal experiments

Tuesday, May 4th, 2004 - Pemetrexed (Alimta®) Study Suggests Advances over Docetaxel (Taxotere®) in Second-Line Non-Small Cell Lung Cancer; Currently, Taxotere® is the only drug approved in the U.S. for second-line treatment of patients with non-small cell lung cancer

Tuesday, May 4th, 2004 - Alimta® Compares Favorably to Taxotere® in the Second-Line Treatment of Non-Small Cell Lung Cancer; Currently, Taxotere® is the only drug approved in the U.S. for second-line treatment of patients with non-small cell lung cancer

Bookmark and Share

Looking for mesothelioma lawyers? Experienced asbestos attorneys.

Please read our disclaimer. Goldberg, Persky & White, P.C.

 

Last Updated: January 13, 2012. 06:25:40 pm.